Overview
Carl E. Stafstrom is a pediatric neurologist, caring for children with epilepsy. Dr. Stafstrom received his medical degree from the University of Washington School of Medicine in Seattle, with residencies at the University of Washington Medical Center and Tufts New England Medical Center, as well as fellowships at Harvard for neurology research and Boston Children’s Hospital in clinical neurophysiology, electroencephalography, and epilepsy. Dr. Stafstrom previously served as Professor of Neurology and Pediatrics at the University of Wisconsin-Madison School of Medicine and Public Health and Chief of Pediatric Neurology at American Family Children’s Hospital at UW Madison.
Dr. Stafstrom is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Epilepsy, Seizures, West Syndrome, Endovascular Embolization, and Deep Brain Stimulation.
His clinical research consists of co-authoring 163 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Neurofibromatosis Type 1 (NF1).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- POS
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
Locations
Floor 5, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Children's Center
Dr. Christine Pratilas is a pediatric medical oncologist at the Sidney Kimmel Comprehensive Cancer Center and Associate Professor of Oncology, Pediatrics & Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine. She joined the Hopkins pediatric sarcoma team in 2014. Dr. Pratilas received her undergraduate degree in Biology from Drew University in New Jersey and her medical degree from UMDNJ - Robert Wood Johnson Medical School (now Rutgers University), where she also completed her internship and residency from 1999 to 2002. From 2002 to 2005 she was a fellow in hematology and oncology in the Memorial Sloan Kettering Cancer Center (MSKCC) Department of Pediatrics, and in the Department of Pediatric Hematology and Oncology at New York Weill Cornell Medical Center. She was a postdoctoral research fellow in Dr. Neal Rosen’s Molecular Oncogenesis Laboratory at MSKCC. From 2006 to 2014 she was attending in Pediatric Oncology at MSKCC, specializing in developmental therapeutics & sarcoma. She has been the director of the pediatric sarcoma program at Hopkins since 2018. Dr. Pratilas focuses her research on cancer-associated pathways and signal transduction, which involves figuring out how a cell’s internal molecular pathways work, and how those pathways can be molecularly controlled. This knowledge is the basis for developing promising new molecularly targeted cancer therapies, which is the focus of Dr. Pratilas’s research. Among her important scientific contributions is advancing our understanding of how certain proteins that can be mutated in cancer, known as RAF kinases (specifically BRAF), affect a cancer cell’s behavior. The research in Dr. Pratilas' laboratory is focused on RAS signal transduction pathways, concentrating on pediatric sarcomas such as rhabdomyosarcoma and malignant peripheral nerve sheath tumors, in order to develop novel therapeutics for children with these tumors. Dr. Pratilas is rated as a Distinguished provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). Her top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Adult Soft Tissue Sarcoma, and Osteotomy.
Roger Packer is a Neurologist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Packer is rated as an Elite provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Gliomatosis Cerebri.
Srivandana Akshintala is a Pediatrics provider in Washington, Washington, D.c.. Dr. Akshintala is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). Her top areas of expertise are Neurofibromatosis, Neurofibromatosis Type 1 (NF1), Neuroendocrine Tumor, Clouston Syndrome, and Thyroidectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EpilepsyDr. Stafstrom isElite. Learn about Epilepsy.
- SeizuresDr. Stafstrom isElite. Learn about Seizures.
- Distinguished
- Absence SeizureDr. Stafstrom isDistinguished. Learn about Absence Seizure.
- Benign Rolandic EpilepsyDr. Stafstrom isDistinguished. Learn about Benign Rolandic Epilepsy.
- Generalized Tonic-Clonic SeizureDr. Stafstrom isDistinguished. Learn about Generalized Tonic-Clonic Seizure.
- Juvenile Myoclonic EpilepsyDr. Stafstrom isDistinguished. Learn about Juvenile Myoclonic Epilepsy.
- Myoclonic EpilepsyDr. Stafstrom isDistinguished. Learn about Myoclonic Epilepsy.
- Spasmus NutansDr. Stafstrom isDistinguished. Learn about Spasmus Nutans.
- Advanced
- Epilepsy in ChildrenDr. Stafstrom isAdvanced. Learn about Epilepsy in Children.
- Epilepsy Juvenile AbsenceDr. Stafstrom isAdvanced. Learn about Epilepsy Juvenile Absence.
- Epilepsy with Myoclonic-Atonic SeizuresDr. Stafstrom isAdvanced. Learn about Epilepsy with Myoclonic-Atonic Seizures.
- Landau-Kleffner SyndromeDr. Stafstrom isAdvanced. Learn about Landau-Kleffner Syndrome.
- Lennox-Gastaut Syndrome (LGS)Dr. Stafstrom isAdvanced. Learn about Lennox-Gastaut Syndrome (LGS).
- Status EpilepticusDr. Stafstrom isAdvanced. Learn about Status Epilepticus.
- Experienced
- 15q11.2 MicrodeletionDr. Stafstrom isExperienced. Learn about 15q11.2 Microdeletion.
- Achalasia Microcephaly SyndromeDr. Stafstrom isExperienced. Learn about Achalasia Microcephaly Syndrome.
- Angelman SyndromeDr. Stafstrom isExperienced. Learn about Angelman Syndrome.
- Aplasia Cutis CongenitaDr. Stafstrom isExperienced. Learn about Aplasia Cutis Congenita.
- Asphyxia NeonatorumDr. Stafstrom isExperienced. Learn about Asphyxia Neonatorum.
- Autism Spectrum DisorderDr. Stafstrom isExperienced. Learn about Autism Spectrum Disorder.